Area of research
Oncology · Hepatology
Research interest
Research focused on Placebo and Bendamustine, with related work in Pembrolizumab, Albuminuria, Chronic lymphocytic leukemia. Notable publications include 'C-C motif-ligand 2 inhibition with emapticap pegol (NOX-E36) in type 2 diabetic patients with albuminuria', 'Olaptesed pegol (NOX-A12) with bendamustine and rituximab: a phase IIa study in patients with relapsed/refractory chronic lymphocytic leukemia', and 'Combined inhibition of CXCL12 and PD-1 in MSS colorectal and pancreatic cancer: modulation of the microenvironment and clinical effects'.